Andrew D. Seidman, MD, from Memorial Sloan-Kettering Cancer Center, discusses breast cancer treatment with surgery and radiotherapy.
Andrew D. Seidman, MD, a professor of medicine at the Weill Cornell Cancer Center and an attending physician at the Memorial Sloan-Kettering Cancer Center, discusses breast cancer treatment with surgery and radiotherapy.
Seidman says that a study by Dr. Emiel J. Rutgers comes at a time when the oncology community has seen that it is possible to perform less surgery without putting patients at an increased risk of lymph node recurrence under the arm or in the axilla. In this study, patients with involvement of a sentinel lymph node were randomly assigned to undergo a complete axillary lymph node dissection or axillary radiotherapy.
The findings from this trial showed that the two approaches were equally effective in controlling breast cancer recurrence, but the radiotherapy led to substantially less swelling of the arm and hand (lymphedema) 1 year and 5 years afterward. Seidman says this represents a new option for patients.
Peritoneal RFS May Be a Stronger Predictor of OS in CRC Peritoneal Metastasis
March 27th 2024In an interview with Targeted Oncology, Muhammad Talha Waheed, MBBS, discussed research on the reliability of using recurrence-free survival as an efficacy end point for trials evaluating patients with colorectal cancer peritoneal metastasis.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen